GL1X · GenesisL1 explorer

Research workbench

AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide adenylyltransferase (Q16AV3)

Analyse AlphaFold monomer V2.0 prediction for probable nicotinate-nucleotide… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

Accession
Q16AV3
Type
protein
Length
199 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0xa7a8Bd7Dd8aC3831b90C08d397E1a831845f1D28
Molecule
Probable nicotinate-nucleotide adenylyltransferase
UniProt
Q16AV3
Pockets
1 · best druggability 0.61

Structure

1 distinct chain · 43% helix, 18% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProbable nicotinate-nucleotide adenylyltransferaseprotein19943% helix, 18% strandQ16AV3

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14130.610.7642empty

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.